Term ends Feb 14, 2030 · High confidence
20-year base term ends Mar 12, 2029
Held by Actelion Pharmaceuticals Ltd.
Filed Jun 5, 2015 as application 14/732,013 · Granted Apr 9, 2019
Base term plus 339 days of patent term adjustment (USPTO delay)
Today
2009
2030
Clock starts
Mar 12, 2009
Mar 12, 2009
Term ends
Feb 14, 2030
Feb 14, 2030
Granted
Apr 9, 2019
Apr 9, 2019
base term
patent term adjustment
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
339
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,785,484, to Feb 14, 2030. The term already ends on or before that date, so the cap shortened nothing.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 339 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 2 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 12, 2009, when application PCT/IB2009/051030, the earliest non-provisional in its chain, was filed (this one was filed Jun 5, 2015) | Mar 12, 2029 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +339 days, USPTO patent term adjustment record | Feb 14, 2030 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,785,484) | resolves to Feb 14, 2030, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Feb 14, 2030 | High confidence |
This family
| US 8,785,484 | In force Jun 2030 | Jun 2030 |
| Application 14/308,598 | Abandoned not computed | not computed |
| Application 14/322,801 | Abandoned not computed | not computed |
| US 10,660,880 | In force Apr 2030 | Apr 2030 |
| US 10,251,867 | this patent Feb 2030 | Feb 2030 |
5 of 6 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 19, 2015 Reel 35866, frame 680 | Brossard, Patrick; Dingemanse, Jasper; Nayler, Oliver; Scherz, Michael; Steiner, Beat | Actelion Pharmaceuticals Ltd. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Feb 2030
Term ends Feb 14, 2030. No further fees fall due before then
Note
The 339 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 8,785,484, ends no earlier than this term, so it caps nothing.
Citations
11
later US patents cite this one
That is top 25% of utility patents granted in 2019 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.